Mariner
PRVA icon

Mariner’s Privia Health PRVA Stock Holding History

Mariner’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521K Buy
20,239
+2,400
+13% +$55.6K ﹤0.01% 2430
2026
Q1 		$367K Buy
17,839
+2,484
+16% +$56K ﹤0.01% 2703
2025
Q4 		$365K Sell
15,355
-1,796
-10% -$43.7K ﹤0.01% 2686
2025
Q3 		$427K Sell
17,151
-19,537
-53% -$420K ﹤0.01% 2557
2025
Q2 		$844K Sell
36,688
-25,879
-41% -$599K ﹤0.01% 1929
2025
Q1 		$1.4M Sell
62,567
-19,289
-24% -$448K ﹤0.01% 1448
2024
Q4 		$1.6M Sell
81,856
-25,062
-23% -$497K ﹤0.01% 1346
2024
Q3 		$1.95M Buy
106,918
+3,262
+3% +$62.2K ﹤0.01% 1202
2024
Q2 		$1.8M Sell
103,656
-1,391
-1% -$24.6K ﹤0.01% 1164
2024
Q1 		$2.06M Buy
105,047
+95,082
+954% +$2.01M ﹤0.01% 1096
2023
Q4 		$229K Buy
9,965
+418
+4% +$9.36K ﹤0.01% 2579
2023
Q3 		$220K Buy
9,547
+868
+10% +$22.1K ﹤0.01% 2428
2023
Q2 		$227K Buy
+8,679
New +$229K ﹤0.01% 2359
2022
Q4 		– Sell
-6,055
Closed -$206K – 2818
2022
Q3 		$206K Buy
+6,055
New +$224K ﹤0.01% 2041

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Mariner's PRVA Position: Q2 2026 in Review

Mariner increased its Privia Health (PRVA) stake by 13% in Q2 2026, buying an estimated $55.6K and bringing the position to 20,239 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

Mariner first reported a position in PRVA in Q3 2022 and has held it in 14 quarters since. The position peaked at $2.06M in Q1 2024. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Mariner held 20,239 shares of Privia Health worth $521K as of Q2 2026.
  • Mariner bought 2,400 Privia Health shares in Q2 2026, an estimated $55.6K.
  • Privia Health made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2430 holding.
  • Mariner first reported a position in Privia Health in Q3 2022 and has held it in 14 quarters since.
  • Mariner's Privia Health position peaked at $2.06M in Q1 2024.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.